Business
AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, announced today changes to the previously announced key dates relating to its proposed rights offering (the “Rights Offering”). Except as expressly amended herein, the terms of the Rights Offering remain unchan
About this update from Aim Immunotech Inc.
[{"type":"image","alt":"AIM ImmunoTech Inc.","displaySize":"","headline":null,"caption":"AIM ImmunoTech Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":160,"url":"https://media.zenfs.com/en/globenewswire.com/c64a717b389cb0d8a4c8889b41b5cabd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ExfZBbISk6KxGeFYkBNhew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyNDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c64a717b389cb0d8a4c8889b41b5cabd","width":300,"height":160}},"lazy":false},{"type":"text","content":"OCALA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, announced today changes to the previously announced key dates relating to its proposed rights offering (the “Rights Offering”). Except as expressly amended herein, the terms of the Rights Offering remain unchanged. Assuming that the Rights Offering is fully subscribed, the Company will receive gross proceeds of $12 million, less expenses related to the Rights Offering.","length":666,"tagName":"p"},{"type":"text","content":"The Subscription Rights will be non-transferable and may only be exercised during the amended subscription period of Wednesday, February 11, 2026 through 5:00 p.m. Eastern Time on Friday, February 27, 2026, unless extended by AIM.","length":230,"tagName":"p"},{"type":"text","content":"The amended calendar for the Rights Offering is now as follows:","length":63,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"February 9, 2026: Ownership Day – in order to be considered a stockholder of record on February 10, 2026, shares should be acquired by this date (open market purchases of Common Stock should be completed by February 9, 2026 to be considered a stockholder of record on the Record Date).","length":285,"tagName":"p"}]},{"val":[{"type":"text","content":"February 10, 2026: Record Date (5:00 p.m. Eastern Time)","length":55,"tagName":"p"}]},{"val":[{"type":"text","content":"February 11, 2026: Distribution Date; Subscription Period Begins","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"February 27, 2026: Subscription Period Ends 5:00 p.m. Eastern Time","length":66,"t...